WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001030822) A NOVEL POLYPEPTIDE - HUMAN dUTP PYROPHOSPHATASE 26 AND THE POLYNUCLEOTIDE ENCODING SAID POLYPEPTIDE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/030822    International Application No.:    PCT/CN2000/000354
Publication Date: 03.05.2001 International Filing Date: 23.10.2000
Chapter 2 Demand Filed:    21.05.2001    
IPC:
C12N 9/14 (2006.01)
Applicants: SHANGHAI BIO ROAD GENE DEVELOPMENT LTD. [CN/CN]; 12th Floor, 3rd Building, 1111 Zhongshan Bei Er Road, Shanghai 200092 (CN) (For All Designated States Except US).
MAO, Yumin [CN/CN]; (CN) (For US Only).
XIE, Yi [CN/CN]; (CN) (For US Only)
Inventors: MAO, Yumin; (CN).
XIE, Yi; (CN)
Agent: SHANGHAI ZHI XIN PATENT AGENT LTD.; 10/F, Italy Building, 446 Zhao Jia Bang Road, Shanghai 200031 (CN)
Priority Data:
99 1 19847.6 26.10.1999 CN
Title (EN) A NOVEL POLYPEPTIDE - HUMAN dUTP PYROPHOSPHATASE 26 AND THE POLYNUCLEOTIDE ENCODING SAID POLYPEPTIDE
(FR) NOUVEAU POLYPEPTIDE, PYROPHOSPHATASE HUMAINE 26 DUTP, ET POLYNUCLEOTIDE CODANT POUR CE POLYPEPTIDE
Abstract: front page image
(EN)The invention discloseS a new kind of polypeptide-human dUTP pyrophosphatase 26 and the polynucleotide encoding said polypeptide and a process for producing the polypeptide by recombinant methods. It also discloseS the method of applying the polypeptide for the treatment of various kinds of diseases, such as cancer, hemopathy, HIV infection, immune diseases and inflammation. The antagonist of the polypeptide and therapeutic use of the same is also disclosed. In addition, it refers to the use of polynucleotide encoding said human dUTP pyrophosphatase 26.
(FR)L'invention concerne un nouveau polypeptide, une pyrophosphatase humaine 26 dUTP, et un polynucléotide codant pour ce polypeptide ainsi qu'un procédé d'obtention de ce polypeptide par des techniques recombinantes d'ADN. L'invention concerne en outre les applications de ce polypeptide dans le traitement de maladies, notamment des tumeurs malignes, de l'hémopathie, de l'infection par VIH, de maladies immunitaires et de diverses inflammations. L'invention concerne aussi l'antagoniste agissant contre le polypeptide et son action thérapeutique ainsi que les applications de ce polynucléotide codant pour la pyrophosphatase humaine 26 dUTP.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)